SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
GB CL CA125
GB CL CA125 is a quantitative CL reagent measuring CA-125 in serum/plasma. Helps support diagnosis and monitoring of gynecological tumors like ovarian cancer. Fast 10-minute test.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  PERFORMANCE>  SPECIFICATION>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This reagent is an in vitro quantitative assay using a sandwich chemiluminescent microparticle immunoassay format to measure CA-125 in human serum or plasma. It requires 10 µL sample and delivers results in approximately 10 minutes. The limit of quantification (LoQ) is 1.50 U/mL. Stored at 2-8°C, avoid direct sunlight and do not freeze. Used clinically as a tumor marker particularly for ovarian cancer diagnosis and monitoring.
PERFORMANCE
Limit of Quantitation (LoQ): 1.50 U/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%
SPECIFICATION
PrincipleSandwich-type chemiluminescent immunoassay 
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume10 μL
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationRUO
ORDERING INFORMATION
Catalogue No.Product
4ACA502GB CL CA125
4ACA51BGB CL CA125-Control
4ACA52BGB CL CA125-Calibrator